4 Analysts Assess Insulet: What You Need To Know
4 Analysts Assess Insulet: What You Need To Know
4 位分析师评估 Insulet：你需要知道的
During the last three months, 4 analysts shared their evaluations of Insulet (NASDAQ:PODD), revealing diverse outlooks from bullish to bearish.
在过去的三个月中，4位分析师分享了他们对Insulet（纳斯达克股票代码：PODD）的评估，揭示了从看涨到看跌的不同前景。
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
下表汇总了他们最近的评级，阐明了过去30天内情绪的变化，并将其与前几个月进行了比较。
In the assessment of 12-month price targets, analysts unveil insights for Insulet, presenting an average target of $217.0, a high estimate of $230.00, and a low estimate of $200.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 0.46%.
在对12个月目标股价的评估中，分析师公布了对Insulet的见解，平均目标股价为217.0美元，最高估计为230.00美元，低估值为200.00美元。随着分析师将平均目标股价下调了0.46％，情绪的负面转变显而易见。
Understanding Analyst Ratings: A Comprehensive Breakdown
了解分析师评级：全面细分
The perception of Insulet by financial experts is...
通过分析师最近的...
登录免费看全文
登录/注册